Most Recent
Consumer law claims dropped in Bayer contraceptive class action
The lead applicant in a class action against Bayer over its allegedly defective Essure contraceptive devices has won court approval to drop her consumer law claims against the German drug maker, with a judge agreeing that the plaintiff's defect and negligence claims had a better chance of succeeding.
Appeal fails in case accusing pharma CEO of assaulting staff with syringe
A former CEO of a global pharmaceutical company has lost his appeal of a ruling throwing out a lawsuit he brought against his former employer after he was terminated in the wake of accusations that he harassed staff and using a syringe to stab multiple employees.
ACCC drops long-running consumer case against NIB
The Australian Competition and Consumer Commission has dropped a consumer case accusing NIB Health Funds of failing to alert customers to coverage changes in their policies, less than a month before trial was set to kick off in the long-running case.
Pharmacor takes aim at Novartis patents for MS drug Gilenya
Generic drug company Pharmacor has fired back in a patent lawsuit by Novartis, filing a cross-claim seeking to invalidate the Swiss drug giant's patents for its blockbuster MS drug Gilenya.
Monash IVF faces potential class action over ‘ineffective’ genetic tests
Costly add-on therapies sold by Monash IVF to thousands of women undergoing IVF -- including pre-implantation genetic testing -- are the targets of a new class action investigation.
Judge mulling $38.4M Estia settlement hears class closure rulings ‘plainly wrong’
A judge weighing a $38.4 million settlement in a shareholder class action against aged care provider Estia Health has been told that two NSW Court of Appeal judgments barring class closure were “plainly wrong”, but in deciding whether to lock group members out of the settlement the judge says he won’t need to grapple with the landmark rulings.
Group size trimmed in aged care class actions over COVID-19 outbreaks
Staff members who worked for two Melbourne aged care providers will be removed as group members in class actions accusing the homes of negligently handling the coronavirus pandemic.
Otzuka, Bristol-Myers lose discovery bid in decade-old fight over Abilify
The companies behind the top selling Abilify medication have lost their latest bid for documents from the Commonwealth in a multimillion dollar dispute over the delayed listing of generic versions of their drug, with a judge saying the material could be only "of the most marginal relevance".
Junior doctors launch second class action in Victoria alleging unpaid overtime
Monash Health and LaTrobe Regional Health Service have been hit with a class action on behalf of junior doctors in Victoria who allege they were denied pay for overtime hours worked over the past six years, the second underpayments class action filed by junior doctors in the state.
Failure to lodge OT claims dooms NSW junior doctors’ class action, court told
NSW Health has hit back at a class action accusing it of failing to pay overtime hours to junior doctors, saying that because they did not submit an overtime claim they were taken to have worked the additional hours “of their own volition”.